Zithromax advisory committee
Executive Summary
One-day and three-day dosing regimens for Pfizer's Zithromax (azithromycin) for the treatment of acute otitis media will be reviewed by FDA's Anti-Infective Drugs Advisory Committee Nov. 7. The meeting will be held at the Holiday Inn in Silver Spring, Md. beginning at 8 a.m